Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice
- PMID: 25199095
- PMCID: PMC4113239
Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice
Abstract
Effective pain medication is important for animal stewardship and valid research results. We compared the pharmacokinetic assessments of standard, immediate-release buprenorphine (Bup IR) and a sustained-release buprenorphine formulation (Bup SR Lab) in male C57BL/6J mice, a mouse strain commonly used in biomedical research. We postulated that the administration of Bup SR Lab would achieve a more persistent blood drug concentration (>1 ng/mL) compared with single-dose Bup IR. The study assumed a blood buprenorphine concentration of 1 ng/mL as the minimum that may result in adequate analgesia, as previously reported. The 7 experimental groups included Bup IR (0.03, 0.05, 0.1, and 2 mg/kg), Bup SR Lab (0.3 and 1.2 mg/ kg), and saline placebo (0.7 mL/100 g). Blood sampling occurred at 0.5, 1, 3, 6, 12, 24, 48, and 72 h for evaluation by using a forensic ELISA. Bup IR at 0.03 and 0.05 mg/kg and Bup SR Lab at 0.3 mg/kg failed to obtain maximal blood concentrations (Cmax) above 1 ng/mL. All other doses (0.1 and 2 mg/kg Bup IR and 1.2 mg/kg Bup SR Lab) reached a Cmax above 1 ng/mL within 3 h after injection. In addition, 1.2 mg/kg Bup SR Lab and 2 mg/kg Bup IR provided blood concentrations above 1 ng/mL for up to 12 h, and 0.1 mg/kg Bup IR achieved this criterion for as long as 3 h. In conclusion, Bup SR Lab at 1.2 mg/kg and Bup IR at 0.1 or 2.0 mg/kg achieve or surpass the published threshold for adequate analgesia in mice.
Figures



Similar articles
-
Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride.J Am Assoc Lab Anim Sci. 2016 Nov;55(6):789-793. J Am Assoc Lab Anim Sci. 2016. PMID: 27931318 Free PMC article.
-
Efficacy of Sustained-Release Buprenorphine in an Experimental Laparotomy Model in Female Mice.J Am Assoc Lab Anim Sci. 2016 Jan;55(1):66-73. J Am Assoc Lab Anim Sci. 2016. PMID: 26817982 Free PMC article.
-
Evaluation of an improved sustained-release buprenorphine formulation for use in mice.Am J Vet Res. 2014 Jul;75(7):619-25. doi: 10.2460/ajvr.75.7.619. Am J Vet Res. 2014. PMID: 24959727
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.Drug Alcohol Depend. 2014 Nov 1;144:1-11. doi: 10.1016/j.drugalcdep.2014.07.035. Epub 2014 Aug 19. Drug Alcohol Depend. 2014. PMID: 25179217 Free PMC article. Review.
Cited by
-
A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models.Sci Rep. 2023 Mar 7;13(1):3824. doi: 10.1038/s41598-023-30641-9. Sci Rep. 2023. PMID: 36882427 Free PMC article.
-
Serum Buprenorphine Concentrations and Behavioral Activity in Mice After a Single Subcutaneous Injection of Simbadol, Buprenorphine SR-LAB, or Standard Buprenorphine.J Am Assoc Lab Anim Sci. 2021 Nov 1;60(6):661-666. doi: 10.30802/AALAS-JAALAS-21-000028. Epub 2021 Nov 5. J Am Assoc Lab Anim Sci. 2021. PMID: 34740385 Free PMC article.
-
Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use.Sci Rep. 2020 Oct 14;10(1):17295. doi: 10.1038/s41598-020-74230-6. Sci Rep. 2020. PMID: 33057103 Free PMC article.
-
Pharmacokinetics of Extended-release Buprenorphine and Clinical Efficacy for Postoperative Pain Management in the Domestic Ferret (Mustela putorius furo).J Am Assoc Lab Anim Sci. 2024 Aug 20;63(5):552-64. doi: 10.30802/AALAS-JAALAS-24-000011. Online ahead of print. J Am Assoc Lab Anim Sci. 2024. PMID: 39164072 Free PMC article.
-
Analgesic treatment limits surrogate parameters for early stress and pain response after experimental subarachnoid hemorrhage.BMC Neurosci. 2019 Sep 18;20(1):49. doi: 10.1186/s12868-019-0531-7. BMC Neurosci. 2019. PMID: 31533626 Free PMC article.
References
-
- Catbagan DL, Quimby JM, Mama KR, Rychel JK, Mich PM. 2011. Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy. Am J Vet Res 72:461–466 - PubMed
-
- Chawarski MC, Schottenfeld RS, O'Connor PG, Pakes J. 1999. Plasma concentrations of buprenorphine 24 to 72 hours after dosing. Drug Alcohol Depend 55:157–163 - PubMed
-
- Christoph T, Kogel B, Schiene K, Meen M, De Vry J, Friderichs E. 2005. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 507:87–98 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous